Citation Impact
Citing Papers
Potential etiologic and functional implications of genome-wide association loci for human diseases and traits
2009 Standout
Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression
1996
The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene
1997 Standout
Use and Abuse of HOMA Modeling
2004 Standout
The Influence of Chromosomal Location on the Expression of Two Transgenes in Mice
1999 StandoutNobel
Presenilins are essential for regulating neurotransmitter release
2009 StandoutNatureNobel
Lipid rafts and signal transduction
2000 Standout
Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women
2007 Standout
Genetic loci controlling body fat, lipoprotein metabolism, and insulin levels in a multifactorial mouse model.
1998
Targeting the mouse genome: a compendium of knockouts (part I)
1995
Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease
2009 Standout
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
2007 Standout
Comparative Analysis of Amyloid-β Chemical Structure and Amyloid Plaque Morphology of Transgenic Mouse and Alzheimer's Disease Brains
2001
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
2022 Standout
Acylation-stimulating Protein (ASP) Deficiency Induces Obesity Resistance and Increased Energy Expenditure in ob/obMice
2002
Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR
1996
Metabolic origins and clinical significance of LDL heterogeneity
2002
Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model
2000
Reduced Body Weight, Adipose Tissue, and Leptin Levels Despite Increased Energy Intake in Female Mice Lacking Acylation-Stimulating Protein1
2000
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis
1998 StandoutNature
Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory
2005 Standout
Peroxisome proliterator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis
1999
Link between heart disease, cholesterol, and Alzheimer's disease: A review
2000 StandoutNobel
Signaling—2000 and Beyond
2000 Standout
Genome-wide Methylation Profiles Reveal Quantitative Views of Human Aging Rates
2012 Standout
Flotillin-Dependent Clustering of the Amyloid Precursor Protein Regulates Its Endocytosis and Amyloidogenic Processing in Neurons
2008 StandoutNobel
Alzheimer's disease
2006 Standout
Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles
2003 Standout
IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.
1997
APP Processing and Synaptic Function
2003
Anti-Aβ Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer's Disease
2011 StandoutNobel
Alzheimer's Disease
2010 Standout
Statin therapy for Alzheimer’s disease
2002
Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction
2006
Measurement of the Interleukin Family Member ST2 in Patients With Acute Dyspnea
2007
The Amyloid State of Proteins in Human Diseases
2012 Standout
β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection
2007 StandoutNobel
Environmental Enrichment Reduces Aβ Levels and Amyloid Deposition in Transgenic Mice
2005 Standout
Protective and pathogenic functions of macrophage subsets
2011 Standout
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Alzheimer's Disease
2004 Standout
Atherosclerosis
2000 StandoutNature
A genetically humanized mouse model for hepatitis C virus infection
2011 StandoutNatureNobel
Altering the Expression in Mice of Genes by Modifying Their 3′ Regions
2004 StandoutNobel
A Cholesterol-Lowering Drug Reduces β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease
2001
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
1996 StandoutNature
Membrane microdomains and caveolae
1999
Atherosclerosis
2001 Standout
Alzheimer's disease: the cholesterol connection
2003
Biomarkers in Heart Failure
2008 Standout
A molecular pathway of neurodegeneration linking α-synuclein to ApoE and Aβ peptides
2008 StandoutNobel
Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions
2009
Lipoprotein Genotype and Conserved Pathway for Exceptional Longevity in Humans
2006
Alternative activation of macrophages
2003 Standout
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
Stem cell-derived polarized hepatocytes
2020 StandoutNobel
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
2007 Standout
Adipose Tissue as an Endocrine Organ
2004 Standout
Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease
2010
Apolipoprotein (apo) E4 enhances amyloid β peptide production in cultured neuronal cells: ApoE structure as a potential therapeutic target
2005
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
2002 StandoutScience
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
The Biology of Vascular Endothelial Growth Factor
1997 Standout
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
Excess heme upregulates heme oxygenase 1 and promotes cardiac ferroptosis in mice with sickle cell disease
2021
Elevated Aβ and Apolipoprotein E in AβPP Transgenic Mice and Its Relationship to Amyloid Accumulation in Alzheimer’s Disease
2000
Contrasting, Species-Dependent Modulation of Copper-Mediated Neurotoxicity by the Alzheimer's Disease Amyloid Precursor Protein
2002
Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions
2010
Targeting the mouse genome: a compendium of knockouts (part II)
1995
A genetically clamped renin transgene for the induction of hypertension
2002 StandoutNobel
A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism
1997
Structure and Function of Sphingolipid- and Cholesterol-rich Membrane Rafts
2000 Standout
Hepatocyte Nuclear Factor 4α (Nuclear Receptor 2A1) Is Essential for Maintenance of Hepatic Gene Expression and Lipid Homeostasis
2001
Cellular uptake of nanoparticles: journey inside the cell
2017 Standout
Different Requirements for Scavenger Receptor Class B Type I in Hepatitis C Virus Cell-Free versus Cell-to-Cell Transmission
2013 StandoutNobel
Works of N. Maeda being referenced
Modulation of Secreted β-Amyloid Precursor Protein and Amyloid β-Peptide in Brain by Cholesterol
1998
Ventricular expression of natriuretic peptides inNpr1 −/− mice with cardiac hypertrophy and fibrosis
2002
Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia.
1994
Mild Dyslipidemia in Mice following Targeted Inactivation of the Hepatic Lipase Gene
2021